Welcome — and thank you for being one of the first people to open this. I started BH Leadership Brief for a simple reason: I wanted one quick, easy to read place that pulled together everything new in behavioral health that actually touches my job — and left out everything that doesn't. I spend my days as a leader on the inpatient psych side of behavioral healthcare, where a CMS rule change, a payer's prior-auth shift, or an unfilled psychiatrist line isn't theoretical — it directly shapes my everyday decision making. This is the read I always wanted: one place that pulls the federal and Colorado policy moves, the clinical and pharmacological developments, the technology and AI shifts, and the workforce signals worth knowing, and quietly skips the rest. No filler, no explaining your own job back to you — just the week's intelligence, sorted by what it changes for your operation, in about ten minutes. I'm glad you're here. Let's get into it.

Weekly intelligence for behavioral health leaders — policy, clinical innovation, technology, workforce, and the week ahead.

The Medicaid work-requirement standard just got narrower, and the build clock is now 30 days out. CMS’s June 1 implementation guidance defines “medically frail” to require both a qualifying condition and documented functional impairment, bars states from exempting on diagnosis alone, and limits self-attestation to 2027; the rule takes effect July 31 as the comment window (docket CMS-2026-2047) closes (CHCS, June 24; Acuity, June 9). State member outreach runs June 30–August 31.

Implication: This converts your SMI and SUD exemptions into a documentation problem: a diagnosis won’t hold coverage, so clinicians will be asked to attest to functional impairment. Build the discharge-documentation and data-feed workflow now — most states will lean on claims and managed-care data first, and your uncompensated-care exposure rides on it. CMS-relevant.

HHS posted $700M-plus in new behavioral health funding, with strings. Secretary Kennedy announced a $96M STREETS NOFO plus $612M across additional programs on June 17, days after SAMHSA’s June 11 release of $40M for eight grant programs; STREETS bars housing-first approaches and prohibited harm-reduction services as a condition of award (HHS, June 17; SAMHSA, June 11).

Operational read: Fresh money is real but ideologically conditioned — read the prohibited-use language before your grants team builds a street-outreach or diversion application around it. The carve-outs may conflict with your existing clinical model.

Joint Commission’s July 1 standards land this week, and Accreditation 360 is moving toward behavioral health. The July 1, 2026 Edition update (posted May 29) adds two certifications — Cyber Resilience Readiness and Outcomes-Driven Certification — and TJC has confirmed the Accreditation 360 framework will extend to behavioral health and human services, with non-hospital implementation dates still being set (Joint Commission, June 2026).

Operational read: The shift from survey-ready to always-ready is the real change; the NPG data-infrastructure model is coming to BH even though you’re not subject to it yet. Standing up performance-measurement plumbing now is cheaper than scrambling when the implementation date posts. Joint Commission-relevant.

No net-new psychiatric approvals this week; the actionable signals are two near-term pipeline events with direct inpatient workflow implications.

A once-monthly olanzapine LAI may drop the 3-hour post-injection watch. Teva’s TEV-’749 (subcutaneous once-monthly olanzapine LAI) is under FDA review on a December 2025 NDA; SOLARIS phase 3 week-56 data showed no evidence of a need for post-injection monitoring — unlike current long-acting olanzapine, which requires REMS certification and a 3-hour observation (Psychiatric Times, June 24).

Operational read: If approved with a clean label, this removes the single biggest staffing and throughput constraint on inpatient olanzapine LAI use. Worth flagging to your pharmacy and nursing leadership now, because it changes the discharge-injection math. Metabolic risk stays an olanzapine risk.

Centanafadine has a July 24 FDA action date. The non-stimulant ADHD candidate carries a PDUFA target action date of July 24, 2026; the final label’s abuse-liability and controlled-substance language will decide where it sits relative to stimulants and existing non-stimulants (Dr. Shapiro medication tracker, June 25).

Operational read: ADHD isn’t your core inpatient driver, but co-occurring presentations are common — a new non-stimulant option with a near-term decision is worth a line in your formulary committee’s watch column.

AI governance just moved ahead of AI adoption, and there’s now a framework for it. A new “Beyond Ambient” white paper and webinar from Core Solutions and OPEN MINDS argues BH organizations are deploying AI faster than they are governing it, with the consequences showing up in documentation quality, compliance exposure, and clinician trust (OPEN MINDS, June 23).

Implication: If you’re piloting ambient documentation without a written governance posture — consent language, a human-decision firewall, vendor data-retention terms — you’re carrying the exposure without the controls. The Texas and California AI-disclosure laws already make several of these requirements, not best practices.

Cyber resilience is now an accreditable line item. Joint Commission’s new Cyber Resilience Readiness certification (effective July 1) and its existing Responsible Use of AI in Healthcare certification signal that data security and AI governance are becoming formal, surveyable domains rather than IT back-office concerns (Joint Commission, June 2026); the White House also issued a June 2 executive order on cybersecurity for AI.

Operational read: When AI governance and cyber posture become certifiable, your vendor contracts and your security program become accreditation artifacts. Pull your ambient-documentation vendor’s data-retention and breach terms into that conversation now.

The Counseling Compact added a sixth operational state this month. Indiana went live June 8, joining Arizona, Georgia, Louisiana, Minnesota, and Ohio as states that can issue interstate practice privileges; 32-plus additional states plus D.C. are completing the technical steps (Counseling Compact, June 2026). Recent graduates accruing supervised hours remain ineligible.

Workforce read: Compact privileges are a faster recruiting and telehealth lever than full state-by-state licensure for independently licensed counselors, but only across operational states, and not for your associate-level pipeline. Map which of your remote hires this actually unlocks before counting on it.

The graduate loan cap that hits the master’s pipeline takes effect July 1. Under H.R. 1 and the Department of Education’s implementing rule, new federal graduate borrowing is capped (about $20,500/year and $100,000 lifetime for most “graduate” programs) and Grad PLUS ends for new borrowers on loans made on or after July 1; counseling, social work, and MFT programs fall under the lower cap (Ensora Health, June 2026).

Workforce read: Master’s-level clinicians deliver most psychotherapy; a tighter training-finance environment is a multi-year supply headwind, not a one-cycle event. Current clinicians and existing loans are unaffected — this is a pipeline story, not a retention one.

•      June 30 — Medicaid work-requirement member outreach window opens (runs through August 31) for states going live January 1; the CMS community-engagement rule’s diagnosis lists and data matches are being built against the July 31 effective date. CMS-relevant.

•      July 1 — Joint Commission’s 2026 mid-year standards take effect, including the new Cyber Resilience Readiness and Outcomes-Driven certifications. Federal graduate loan caps and the Grad PLUS termination also begin for new loans; HRSA’s annual HPSA designation withdrawals generally post on or around this date.

•      July 1 –  August 15 — IPFQR Data Accuracy and Completeness Acknowledgement (DACA) attestation window in the HQR system for the FY2027 payment determination; the new Psychiatric Inpatient Experience (PIX) survey moves toward mandatory reporting. Confirm your QR team is scheduled. CMS-relevant.

•      July 13 — SAMHSA Behavioral Health & Community Safety Partnerships NOFO (SM-26-023) application deadline.

•      July 24 — FDA target action date for centanafadine (non-stimulant ADHD).

•      July 31 — CMS Medicaid community-engagement IFR effective date and comment-period close converge (docket CMS-2026-2047); early-adopter states Montana and Arkansas begin enforcement / soft implementation around July 1.

The narrow “medically frail” standard and the July build clocks turn coverage into a documentation problem — the work this week is in your discharge paperwork and your QR calendar, not in the next drug launch.

Sources

–    Center for Health Care Strategies, “A Summary of Federal Medicaid Work Requirements,” updated June 24, 2026

–    Acuity (Acuity Media Network), “CMS Medicaid Work Requirements: Behavioral Health Exemptions,” June 9, 2026

–    KFF, Medicaid Work Requirements tracker, updated June 23, 2026

–    HHS.gov, “Secretary Kennedy Announces Over $700 Million in New Funding,” June 17, 2026

–    SAMHSA / HHS.gov, “SAMHSA Announces $40 Million in Funding Opportunities,” June 11, 2026

–    Joint Commission, “Joint Commission News — June 2026” (July 1 E-dition update; CRR and ODC certifications), June 2026

–    Circa Behavioral Health, “Joint Commission 2026 Updated Standards for Behavioral Health” (Accreditation 360 rollout), 2026

–    Psychiatric Times, “February 2026 in Review: Updates on the Psychiatric Treatment Pipeline” (TEV-’749 olanzapine LAI), June 24, 2026

–    Psychiatric Times, “NDA Accepted: Olanzapine Extended-Release Injectable Suspension,” June 2026 (no post-injection monitoring signal)

–    Arnold Shapiro, MD, “Psychiatric Medications: What Just Arrived and What’s Coming Next,” updated June 25, 2026 (centanafadine PDUFA July 24, 2026)

–    OPEN MINDS / Core Solutions, “Beyond Ambient: An AI Governance Framework for Behavioral Health Leaders,” June 23, 2026

–    AHA Market Scan / White House, executive order on cybersecurity for AI, June 2, 2026

–    Counseling Compact (counselingcompact.gov) and Arizona BBHE, Indiana go-live June 8, 2026

–    Ensora Health, “Federal Behavioral Health Policy Changes 2025–2026” (graduate loan caps, Grad PLUS), June 2026

–    Medisolv, “2025 IPFQR Reporting Requirements” (DACA window July 1–August 15, 2026; PIX survey), 2026

–    HRSA, Designated HPSA Statistics, Q2 FY2026 (data as of March 31, 2026; quarterly report generated June 23, 2026)

–    SAMHSA, BH-CSP NOFO (SM-26-023), application due July 13, 2026

–    KFF, “An Early Look at Policy Decisions as States Get Ready to Implement Work Requirements” (Montana July 1, Arkansas soft-launch July 1), May 20, 2026

Make sure to subscribe so you don’t miss the next newsletter and you stay informed on the updates shaping behavioral healthcare in Colorado and the nation.